← Issue №19/ week of Nov 8, 2026/Pancreas/Biliary

Conditional Survival of Gallbladder Cancer After Curative-Intent Surgery: Impact of Disease Stage, Surgical Extent, and Adjuvant Therapy.

From GI Signals issue №19: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Pancreas/Biliary retrospective · n=641 · Nov 5, 2026 · J Hepatobil Pancreat Sci · IF 3.8

Conditional Survival of Gallbladder Cancer After Curative-Intent Surgery: Impact of Disease Stage, Surgical Extent, and Adjuvant Therapy.

New evidencecholangiocarcinoma
Clinical takeawayUse conditional survival to update prognosis for patients who have survived years after resection; the better course with extended cholecystectomy and adjuvant therapy in stage II-III is a retrospective association.
What it foundFive-year conditional overall survival (COS) increased from 69.4% at baseline to 74.0% among patients surviving 5 years, with Stage III patients showing the largest improvement (45.9%-69.4%).
ContextThis study refines prognostication in gallbladder cancer by introducing conditional survival estimates, which evolve over time, unlike conventional static survival estimates. The findings apply to patients who have undergone curative-intent resection, with specific attention to Stage II-III disease.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Kim HS … Kim H · Journal of Hepato-Biliary-Pancreatic Sciences · IF 3.8 · PubMed ↗Permalink
← Read the whole of issue №19 Every paper GI Signals surfaces gets a page like this one. All issues